Literature DB >> 23552967

Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine.

Benjamin S Daniel, Dedee F Murrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23552967     DOI： 10.1001/jamadermatol.2013.1463

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

1.  Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas.

Authors:  Anna J Nichols; Amber Heyna Allen; Shahjahan Shareef; Evangelos V Badiavas; Robert S Kirsner; Tim Ioannides
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

2.  Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series.

Authors:  Simon Bossart; Valentina Imstepf; Robert E Hunger; S Morteza Seyed Jafari
Journal:  Acta Derm Venereol       Date:  2020-03-12       Impact factor: 3.875

Review 3.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

4.  Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult.

Authors:  Sara B Ferguson; Elisa S Gallo
Journal:  JAAD Case Rep       Date:  2017-07-26

5.  Resolution of novel human papillomavirus-induced warts after HPV vaccination.

Authors:  Steffi Silling; Ulrike Wieland; Marko Werner; Herbert Pfister; Anja Potthoff; Alexander Kreuter
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.